AZoLifeSciences on MSN
Proteomics approaches to overcome undruggable targets in disease
This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...
Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...
New findings from Karolinska Institutet reveal how the gene HNRNPU coordinates several fundamental molecular processes during ...
Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to nonunion ...
New findings from Karolinska Institutet reveal how the gene HNRNPU coordinates several fundamental molecular processes during ...
Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...
Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, ...
Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.
Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.
AZoLifeSciences on MSN
Single-cell atlas reveals how melanoma evades the immune system
Integrative analysis of immune ecotypes in skin cancers highlights metabolic reprogramming and macrophage polarization as key ...
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, characteristic patterns of intestinal inflammation. However, there is now substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results